Corbus Pharmaceuticals Statistics Share Statistics Corbus Pharmaceuticals has 12.26M
shares outstanding. The number of shares has increased by 1.6%
in one year.
Shares Outstanding 12.26M Shares Change (YoY) 1.6% Shares Change (QoQ) 0.04% Owned by Institutions (%) 0% Shares Floating 10.71M Failed to Deliver (FTD) Shares 5,453 FTD / Avg. Volume 3.76%
Short Selling Information The latest short interest is 1.21M, so 9.89% of the outstanding
shares have been sold short.
Short Interest 1.21M Short % of Shares Out 9.89% Short % of Float 12.32% Short Ratio (days to cover) 12.46
Valuation Ratios The PE ratio is -3.2 and the forward
PE ratio is -1.87.
Corbus Pharmaceuticals's PEG ratio is
0.05.
PE Ratio -3.2 Forward PE -1.87 PS Ratio 0 Forward PS 22.7 PB Ratio 0.9 P/FCF Ratio -3.08 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Corbus Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 12.94,
with a Debt / Equity ratio of 0.02.
Current Ratio 12.94 Quick Ratio 12.94 Debt / Equity 0.02 Debt / EBITDA -0.09 Debt / FCF -0.08 Interest Coverage -26.03
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.44M Employee Count 28 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -81.24% in the
last 52 weeks. The beta is 3.09, so Corbus Pharmaceuticals's
price volatility has been higher than the market average.
Beta 3.09 52-Week Price Change -81.24% 50-Day Moving Average 8.93 200-Day Moving Average 9.35 Relative Strength Index (RSI) 56.38 Average Volume (20 Days) 144,980
Income Statement
Revenue n/a Gross Profit -600K Operating Income -48.72M Net Income -40.21M EBITDA -37.74M EBIT -38.34M Earnings Per Share (EPS) -3.68
Full Income Statement Balance Sheet The company has 17.2M in cash and 3.24M in
debt, giving a net cash position of 13.96M.
Cash & Cash Equivalents 17.2M Total Debt 3.24M Net Cash 13.96M Retained Earnings -476.89M Total Assets 125.08M Working Capital 109.49M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -41.79M
and capital expenditures 0, giving a free cash flow of -41.79M.
Operating Cash Flow -41.79M Capital Expenditures n/a Free Cash Flow -41.79M FCF Per Share -3.83
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields CRBP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CRBP is $52,
which is 425.8% higher than the current price. The consensus rating is "Buy".
Price Target $52 Price Target Difference 425.8% Analyst Consensus Buy Analyst Count 9
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 14, 2023. It was a
backward
split with a ratio of 1:30.
Last Split Date Feb 14, 2023 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -1.11 Piotroski F-Score 2
